Anzeige
Mehr »
Login
Donnerstag, 27.02.2025 Börsentäglich über 12.000 News von 688 internationalen Medien
10-faches Wachstum bis 2030? Warum KI-Aktien jetzt die größten Gewinnchancen bieten!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2P5N7 | ISIN: FI4000330972 | Ticker-Symbol: 4YL
Frankfurt
27.02.25
08:05 Uhr
1,214 Euro
+0,010
+0,83 %
Branche
Nanotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
NANOFORM FINLAND OYJ Chart 1 Jahr
5-Tage-Chart
NANOFORM FINLAND OYJ 5-Tage-Chart
RealtimeGeldBriefZeit
1,1321,15615:55

Aktuelle News zur NANOFORM FINLAND Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
07:10Nanoform Finland Oyj: Nanoform 2024 report: Deal discussions around product kernels intensify105Company Announcement Nanoform Finland Plc February 27, 2025 08:10 a.m. Finnish time / 07:10 a.m. Swedish time Nanoform 2024 report: Deal discussions around product kernels intensify After a strong...
► Artikel lesen
13.02.Invitation to Nanoform's Q4 and FY 2024 Report Presentation2
18.12.24 Nanoform Finland Plc - Manager's Transactions - Edward Hæggström3
18.12.24Nanoform Finland Plc - Managers' transactions - Antonio Da Silva4
18.12.24Nanoform Finland Plc - Manager's Transactions - Albert Hæggström1
18.12.24The Board of Directors of Nanoform Finland Plc decided on issue of stock options under an option program open to all employees2
18.12.24Nanoform Finland Plc - Manager's Transactions - Peter Hänninen3
19.11.24Nanoform Finland Plc - Manager's Transactions - Albert Hæggström2
NANOFORM FINLAND Aktie jetzt für 0€ handeln
19.11.24Nanoform Finland Plc - Manager's Transactions - Peter Hänninen2
18.11.24Nanoform Finland Oyj: Nanoform Q3 2024 report: Record number of new projects signed576Company Announcement Nanoform Finland Plc November 18, 2024 08:10 a.m. Finnish time / 07:10 a.m. Swedish time Nanoform Q3 2024 report: Record number of new projects signed A record number of new...
► Artikel lesen
04.11.24Invitation to Nanoform's Q3 2024 Report Presentation2
25.10.24Disclosure as attachment of the Nanoform 2022 Report of the Board of Directors and Financial Statements which were previously linked to a Company Release2
22.10.24Share subscriptions based on Nanoform Finland Plc's stock options 2/20191
05.09.24Nanoform and Celanese Expand Collaboration into Long-Acting Biologics Delivery Through Small Implants5
15.08.24NANOFORM COLLABORATES WITH TAKEDA ON THEIR PLASMA-DERIVED THERAPY DEVELOPMENT841HELSINKI, Aug. 15, 2024 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform"), the medicine performance-enhancing company, today announced that it is to enter into a pre-clinical development...
► Artikel lesen
30.05.24Nanoform's biologics technology showcased by large pharma at drug delivery conference; Nanoenzalutamide and nanoapalutamide partnering discussions progress as planned627HELSINKI, May 30, 2024 /PRNewswire/ -- Manufacturing of GMP material in Project Nanoenzalutamide commenced. EU/US pivotal studies are planned to start in 4Q24, with the read-out in 1Q25....
► Artikel lesen
09.04.24Nanoform and PlusVitech partner to repurpose aprepitant as a treatment for lung cancer884Nanoform Finland Plc April 9, 2024 09.00 EEST / 08.00 CEST HELSINKI, April 9, 2024 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform"), the medicine performance-enhancing company...
► Artikel lesen
17 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1